Evaluation of a novel semi-automated HPLC procedure for whole blood cyclosporin A confirms equivalence to adjusted monoclonal values from Abbott TDx

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 2, 2005, Pages 228-236

  Roberts, Norman B ^a   Dutton, John ^a   Higgins, Gerald ^a   Allars, Lesley ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Abbott; Cyclosporin; HPLC; Liquid chromatography mass spectrometry (LC MS); Metabolite interference; Monoclonal; Polyclonal

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN D;

ACCURACY; ARTICLE; AUTOMATION; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; ONLINE SYSTEM; PERFORMANCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANTIBODIES; ANTIBODIES, MONOCLONAL; AUTOMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; CYCLOSPORINS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 14944343700     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.039     Document Type: Article

References (26)

1. Holt DW, Johnston A, Roberts NB, Tredger JM, Trull AK. Methodological and clinical aspects of cyclosporine monitoring: report of the Association of Clinical Biochemists Task Force. Ann Clin Biochem 1994;31:420-46.
2. Andrews DJ, Cramb R. Cyclosporin: revisions in monitoring guidelines and review of current analytical methods. Ann Clin Biochem 2002;39:424-35.
3. Harris RZ, Jang GR, Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokin 2003;42:1078-88.
4. Ptachinski RJ, Burckart G J, Rosenthal JT, Ventkataramanan R, Howrie DL, Taylor FJ, et al. Cyclosporin pharmacokinetics in children following a cadaveric renal transplantation. Transplant Proc 1986;18:766-7.
5. Lira JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics. Clin Pharmacokin 2003;42:59-98.
6. Soldin SJ, Steele BW, Witte DL, Wang E, Elin RJ. Lack of specificity of cyclosporine immunoassays. Arch Pathol Lab Med 2003;127:19-22.
7. Lensmeyer GL, Wiebe DA, Carlson IH. Distribution of cyclosporine a metabolites among plasma and cells in whole blood: effect of temperature haematocrit and metabolite concentration. Clin Chem 1989;35:56-63.
8. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific. Clin Chem 1999;45:371-81.
9. Roberts NB, Dutton J, Tewari A, Bone M J, Sells RA, Ward RG, et al. A method of relating whole blood cyclosporin results by HPLC to Abbott TDx monoclonal and polyclonal immunoassays. Ann Clin Biochem 1995;32:208-9.
10. Holt DW, Johnston A, Kahan BD, Morris RG, Oellerich M, Shaw LM. New approaches to cyclosporin monitoring raise further concerns about analytical techniques. Clin Chem 2000;46:8725-74.
11. Streit F, Armstrong VW, Oellerich M. Rapid liquid-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus and cyclosporin A in whole blood. Clin Chem 2002;6:955-8.
12. Keevil BG, Tierney DP, Cooper DP, Morris MR. Rapid liquid chromatography-tandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range. Clin Chem 2002;48:69-76.
13. Halmingh O, Kerkdijk H. An improved on-line SPE-HPLC method for cyclosporin A in whole blood. Application Info 23. Emmen, The Netherlands: Spark Holland, 1997.
14. Andrews DJ, Cramb R. Cyclosporin: revisions in monitoring guidelines and review of current analytical methods. Ann Clin Biochem 2002;39:424-35.
15. Hamwi A, Salomon A, Steinbrugger R, Fritzer-Szekeres M, Sger W J, Szekeres T. Cyclosporin metabolism in patients after kidney, bone marrow, heart-lung and liver transplantation in the early and late post-transplant periods. Am J Clin Pathol 2002:114:50-65.
16. McBride JH, Kim SS, Rodgerson DO, Reyes AF, Ota MK. Measurement of cyclosporin by liquid chromatography and three immunoassays in blood from liver, cardiac and renal transport recipients. Clin Chem 1992; 30:2300-6.
17. Tredger JD, Roberts N, Sherwood R, Higgins G, Keating J. Comparison of five cyclosporin immunoassays with HPLC. Clin Chem Lab Med 2000;38:1205-7.
18. Vidal C, Kirchner GI, Wunsch G, Sewing KF. Automated simultaneous quantification of the immunosuppressants 40-O-(2-hydroxyethyl) rapamycin and cyclosporine. Clin Chem 1998;44:1275-82.
19. Roberts NB, Cooper D, Morris M. Measurement of cyclosporine and two major metabolites by LC tandem mass spectrometry. In: Proceedings of the ACB National Meeting 2002, Poster 102, 2220:47.
20. Roberts NB, Higgins G, butler M, Clark RE. The value of mono, poly and HPLC equivalent measurements for whole blood cyclosporin (CYA) monitoring after bone marrow transplantation. In: Embody 2000, Cambridge, UK, Poster 289, 2000:153.
21. Sanderson J, Ansari A, Marinaki T, Duley J. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy. Ann Clin Biochem 2004;41:294-302.
22. Patsalos PN, Stephenson TJ, Krishna S, Elyas AA, Lascelles PT, Wiles CM. Side-effects induced by carbazepine-10-11-epoxide. Lancet 1985;ii:496.
23. Holt DW. Monitoring of mycophenolic acid. Ann Clin Biochem 2002;39:173-83.
24. Shipkova M, Schutz E, Armstrong VW, Niedmann PD, Oellerich M, Wieland E. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and EMIT. Clin Chem 2000;46:365-72.
25. Back D, Gatti G, Fletcher C, Garaffo R, Haubrich R, Hoetelmans R, et al. Therapeutic monitoring in HIV infection; current status and future directions. AIDS 2001; 159(Suppl 1):S3-35.
26. Trull AK. Therapeutic monitoring of tacrolimus. Ann Clin Biochem 1998;35:167-80.